Sort
82,697 grants matching “vaccine development”
Modeling, Spatial, Statistics
$945,379Ira M Longini · Fred Hutchinson Cancer Research Center · U54 · FY2015 · GM
Preclinical characterization of a multivalent killed Filovirus/Rabies vaccine
$945,119Matthias Johannes Schnell · Thomas Jefferson University · R01 · FY2014 · AI
Chimeric Alphavirus Vaccines for Chikungunya
$945,118Scott C Weaver · University Of Texas Med Br Galveston · U01 · FY2010 · AI
Self-Assembling Spike-EBR Nanoparticles as a Vaccine Platform Technology Against SARS-CoV-2 and Future Pandemic Coronaviruses
$945,000Magnus Adrian Gero Hoffmann · J. David Gladstone Institutes · DP5 · FY2025 · OD
Targeting Feedback Circuitry for Antiviral Therapy
$944,989Leor S Weinberger · J. David Gladstone Institutes · R01 · FY2024 · AI
Modulation of the immune response to B cell lineage-based immunization by other immune interventions administered in infancy
$944,979Genevieve Giny Fouda Amou Ou · Weill Medical Coll Of Cornell Univ · P01 · FY2025 · AI
Biocontainment Research Support Service(s) Core
$944,931Rachel M Olson · University Of Missouri-Columbia · UC7 · FY2023 · AI
Task V34: Master Cell Banks Manufacturing for Next Generation SARS-CoV-2 Vaccines
$944,900Heidi Trusheim · Idt Biologika Gmbh · N01 · FY2024 · AI
NSF Convergence Accelerator - Track D: Data-Driven Disease Control and Prevention in Veterinary Health
$944,875Beatriz Martinez Lopez · University Of California-Davis · · FY2020 · TIP
Antibody Based Therapeuticcs for Chikungunya Virus
$944,844Michael S. Diamond · Washington University · R01 · FY2012 · AI
A NOVEL, LOGICAL APPROACH TO HIV VACCINE DEVELOPMENT
$944,842University Of Wisconsin Madison · R01 · FY2002 · AI
Baylor College of Medicine Clinical Trial Unit
$944,697William Thomas Shearer · Baylor College Of Medicine · UM1 · FY2013 · AI
Vaccine Development for Oral Carcinoma
$944,598University Of Pittsburgh At Pittsburgh · P01 · FY2003 · DE
Phase I Trial to Evaluate Cytomegalovirus Therapeutics - VTEU
$944,454Mark Joseph Mulligan · Emory University · N01 · FY2014 · AI
Personalized Cystic Fibrosis Therapy and Research Center
$944,438Anjaparavanda P Naren · Cincinnati Childrens Hosp Med Ctr · P30 · FY2024 · DK
Fox COBRE Phase II Admin Core
$944,312Joseph M Fox · University Of Delaware · P20 · FY2023 · GM
Structure-Based Design of Drugs for Target
$944,198Rutgers The St Univ Of Nj New Brunswick · P01 · FY2002 · GM
Develop, Optimize and Commercialize UltraMarathonRT: A new enzyme for unbiased transcriptomic and epitranscriptomic characterization of RNAs regardless of length or composition.
$944,054Li-Tao Guo · Rnaconnect Inc · R44 · FY2025 · GM
Novel vaccine strategies to induce V2 apex-directed broad neutralizing antibodies
$943,932Laurent Karl Verkoczy · San Diego Biomedical Research Institute · R01 · FY2019 · AI
A Novel, Logical Approach to HIV Vaccine Development
$943,623David I Watkins · University Of Wisconsin-Madison · R01 · FY2008 · AI
Structural studies of native-like SOSIP trimers
$943,450Ian A Wilson · Weill Medical Coll Of Cornell Univ · P01 · FY2019 · AI
Therapeutic Use of an Enhanced Form of CD4-Ig
$943,250Michael R. Farzan · Scripps Florida · R37 · FY2018 · AI
An Orally Delivered Booster Vaccine Candidate for Hepatitis B
$943,211John A. Howard · Applied Biotechnology Institute · R44 · FY2012 · AI
Global Analysis of Cellular Networks Involved In Restriction of HIV Replication
$943,141Sumit K Chanda · Salk Institute For Biological Studies · P01 · FY2012 · AI
Spherical Nucleic Acid nano-architectures as first-in-class cGAS agonists for the immunotherapeutic treatment of Glioblastoma.
$943,101Alexander H. Stegh · Washington University · R01 · FY2025 · CA